Aurinia Pharmaceuticals Inc. (AUPH) P/E ratio

P/E ratio today
6.8×

Only 2 fiscal years of P/E ratio are on record here for Aurinia Pharmaceuticals Inc. (AUPH); a history needs at least 3. Aurinia Pharmaceuticals Inc. (AUPH) trades at 6.8× its earnings per share over the last twelve months. Figures as of 18 Nov 2026, 09:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
6.8×
P/E ratio, fiscal 2025
7.7×
Change on fiscal 2024
−96.6%
Fiscal years on record
22024–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/E ratio needs at least 3 fiscal years; 2 are on record here for Aurinia Pharmaceuticals Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Aurinia Pharmaceuticals Inc. P/E ratio, year by year

Aurinia Pharmaceuticals Inc. (AUPH) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today6.8×—$15.40—
20257.7× 96.6% down$15.95$2.07
2024224.5×—$8.98$0.04
2023——$8.99-$0.54
2022——$4.32-$0.76
2021——$22.87-$1.40
2020——$13.83-$0.87
2019——$20.26-$0.95
2018——$6.82—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on AUPH

Aurinia Pharmaceuticals Inc., figure by figure

Aurinia Pharmaceuticals Inc. (AUPH) overview: price, valuation and scorecard

Aurinia Pharmaceuticals Inc. P/E ratio: questions and answers

What is Aurinia Pharmaceuticals Inc.'s P/E ratio?

Aurinia Pharmaceuticals Inc. (AUPH) trades at 6.8× its earnings per share over the last twelve months.

How is Aurinia Pharmaceuticals Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Aurinia Pharmaceuticals Inc. it is on record here for 2 fiscal years, 2024 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Aurinia Pharmaceuticals Inc. (AUPH) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/AUPH/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.